Basic Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7324-7339
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Figure 4
Figure 4 Prion protein immunocytochemistry in controls and pancreatic ductal adenocarcinoma. A: Prion protein immunocytochemistry in controls. Few particles of gold prion protein (PrPc) are evident (arrows) in the cytosol (magnification: 6000 ×, scale bar: 800 nm); B: Few particles of gold PrPc are evident (arrows) in the nucleus (magnification: 8000 ×, scale bar: 500 nm); C: Prion protein immunocytochemistry in pancreatic ductal adenocarcinoma. The arrows highlight some of the PrPc immuno-gold particles in the nucleus (magnification: 8000 ×, scale bar: 500 nm); D: The arrows highlight some of the PrPc immuno-gold particles in the cytosol (magnification: 7000 ×, scale bar: 600 nm).